News

Respiratory infections in early years of life linked to celiac disease
- Author:
- Lori Laubach
Children with a family history of celiac disease with a propensity for respiratory infections may be at risk.
News

FDA grants accelerated approval for treatment of Chagas disease in children
- Author:
- Lori Laubach
Benznidazole, an antiparasitic drug, is the first treatment approved in the United States for treating the infection.
News

Initiation of ART beneficial in reducing all-cause mortality in AIDS-free patients
- Author:
- Lori Laubach
Starting ART ASAP benefits HIV-positive patients over 50 years of age.
News

FDA approves once-daily treatment for hyperuricemia in gout
- Author:
- Lori Laubach
Duzallo is a fixed-dose combination of lesinurad 200 mg and allopurinol 300 mg and will also be available as lesinurad 200 mg plus allopurinol 200...
News

Safety alert for intragastric balloon systems
- Author:
- Lori Laubach
Causes of patient deaths are not known, but close monitoring of patients is recommended.
News

Safety alert for intragastric balloon systems
- Author:
- Lori Laubach
Causes of patient deaths are not known, but close monitoring of patients is recommended.
News
Painful autoimmune neuropathy may mimic Guillain-Barré syndrome
- Author:
- Lori Laubach
Be on the lookout for acute transient immune responses against small nerve fibers in patients suspected of having Guillain-Barré syndrome.
News

FDA approves new treatment for adults with HCV
- Author:
- Lori Laubach
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
News
Course and outcome of Guillain-Barré syndrome measured in ongoing study
- Author:
- Lori Laubach
More than 1,500 patients have been enrolled so far.
News

FDA approves abatacept for adults with psoriatic arthritis
- Author:
- Lori Laubach
The approval expands the approved indications of abatacept to three autoimmune diseases.
News

Cotempla XR-ODT approved for children, adolescents with ADHD
- Author:
- Lori Laubach
Methylphenidate for ADHD now comes in a more convenient disintigrating tablet.
News

Mydayis approved for teens, adults with ADHD
- Author:
- Lori Laubach
Treatment can lead to improved symptoms of ADHD that can last up to 16 hours, phase III studies show.
News
PBC incidence remains stable in rural parts of U.S.
- Author:
- Lori Laubach
Researchers conducted a population-based cohort study of PBC cases in the midwestern United States between 1992 and 2011.
News

FDA approves Sapien 3 transcatheter valve for bioprosthetic valve failure
- Author:
- Lori Laubach
Patients at high risk can now avoid open surgery when prosthetic valves fail.
News
Parkinsonian symptoms at diagnosis raise synucleinopathy mortality risk
- Author:
- Lori Laubach
Causes of death also varied with incident symptoms of parkinsonism.